Francisco Estrada-Rojo

Francisco Estrada-Rojo

Auto-generated profile, based on publicly available information

Francisco Estrada-Rojo

National Autonomous University of México

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MMMarina Martínez
Marina Martínez
JMJulio Morales-Gomez
Julio Morales-Gomez
RGRuben Gonzalez-Rivera
Ruben Gonzalez-Rivera
CHCarla Hernandez-Enriquez
Carla Hernandez-Enriquez
APAdan Perez-Arredondo
Adan Perez-Arredondo
LNLuz Navarro
Luz Navarro
The endocannabinoid system is a component of the neuroprotective mechanisms that an organism displays after traumatic brain injury (TBI). A diurnal variation in several components of this system has been reported. This variation may influence the recovery and survival rate after TBI. We have previously reported that the recovery and survival rate of rats is higher if TBI occurs at 1:00 than at 13:00. This could be explained by a diurnal variation of the endocannabinoid system. Here, we describe the effects of anandamide administration in rats prior to the induction of TBI at two different times of the day: 1:00 and 13:00. We found that anandamide reduced the neurological damage at both times. Nevertheless, its effects on bleeding, survival, food intake, and body weight were dependent on the time of TBI. In addition, we analyzed the diurnal variation of the expression of the cannabinoid receptors CB1R and CB2R in the cerebral cortex of both control rats and rats subjected to TBI. We found that CB1R protein was expressed more during the day, whereas its mRNA level was higher during the night. We did not find a diurnal variation for the CB2R. In addition, we also found that TBI increased CB1R and CB2R in the contralateral hemisphere and disrupted the CB1R diurnal cycle.

Verified
Journal Article
Open access
PDF file
MMMarina Martínez
Marina Martínez
MSMaribel Soto-Nuñez
Maribel Soto-Nuñez
ETErika Tabla-Ramon
Erika Tabla-Ramon
BSBarbara Solis
Barbara Solis
RGRuben Gonzalez-Rivera
Ruben Gonzalez-Rivera
LNLuz Navarro
Luz Navarro
Cathepsin B is one of the major lysosomal cysteine proteases involved in neuronal protein catabolism. This cathepsin is released after traumatic injury and increases neuronal death; however, release of cystatin C, a cathepsin inhibitor, appears to be a self-protective brain response. Here we describe the effect of cystatin C intracerebroventricular administration in rats prior to inducing a traumatic brain injury. We observed that cystatin C injection caused a dual response in post-traumatic brain injury recovery: higher doses (350 fmoles) increased bleeding and mortality, whereas lower doses (3.5 to 35 fmoles) decreased bleeding, neuronal damage and mortality. We also analyzed the expression of cathepsin B and cystatin C in the brains of control rats and of rats after a traumatic brain injury. Cathepsin B was detected in the brain stem, cerebellum, hippocampus and cerebral cortex of control rats. Cystatin C was localized to the choroid plexus, brain stem and cerebellum of control rats. Twenty-four hours after traumatic brain injury, we observed changes in both the expression and localization of both proteins in the cerebral cortex, hippocampus and brain stem. An early increase and intralysosomal expression of cystatin C after brain injury was associated with reduced neuronal damage.

14 May 2018 in BioMed Research International
Verified
Journal Article
Open access
PDF file
ECElvia Coballase
Elvia Coballase
LNLuz Navarro
Luz Navarro
JOJ. L. Ortiz
J. L. Ortiz
LVL. Verdugo-Díaz
L. Verdugo-Díaz
Juan Manuel GALLARDOJuan Manuel GALLARDO
Juan Manuel GALLARDO
FEF. Estrada-Rojo
F. Estrada-Rojo
Stress is a state of vulnerable homeostasis that alters the physiological and behavioral responses. Stress induces oxidative damage in several organs including the brain, liver, kidney, stomach, and heart. Preliminary findings suggested that the magnetic stimulation could accelerate the healing processes and has been an effective complementary therapy in different pathologies. However, the mechanism of action of static magnetic fields (SMFs) is not well understood. In this study, we demonstrated the effects of static magnetic fields (0.8 mT) in a restraint stressed animal model, focusing on changes in different markers of oxidative damage. A significant increase in the plasma levels of nitric oxide (NO), malondialdehyde (MDA), and advanced oxidation protein products (AOPP), and a decrease in superoxide dismutase (SOD), glutathione (GSH), and glycation end products (AGEs) were observed in restraint stress model. Exposure to SMFs over 5 days (30, 60, and 240 min/day) caused a decrease in the NO, MDA, AGEs, and AOPP levels; in contrast, the SOD and GSH levels increased. The response to SMFs was time-dependent. Thus, we proposed that exposure to weak-intensity SMFs could offer a complementary therapy by attenuating oxidative stress. Our results provided a new perspective in health studies, particularly in the context of oxidative stress.

21 February 2018 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
FEFrancisco Estrada-Rojo
Francisco Estrada-Rojo
JMJulio Morales-Gomez
Julio Morales-Gomez
ECElvia Coballase
Elvia Coballase
MMMarina Martínez
Marina Martínez
LNLuz Navarro
Luz Navarro
Data from our laboratory suggest that recovery from a traumatic brain injury depends on the time of day at which it occurred. In this study, we examined whether traumatic brain injury -induced damage is related to circadian variation in N‐methyl‐d‐aspartate receptor expression in rat cortex. We confirmed that traumatic brain injury recovery depended on the time of day at which the damage occurred. We also found that motor cortex N‐methyl‐d‐aspartate receptor subunit NR1 expression exhibited diurnal variation in both control and traumatic brain injury-subjected rats. However, this rhythm is more pronounced in traumatic brain injury—subjected rats, with minimum expression in those injured during nighttime hours. These findings suggest that traumatic brain injury occurrence times should be considered in future clinical studies and when designing neuroprotective strategies for patients.

6 December 2021 in Toxics
Verified
Journal Article
Open access
PDF file
TLTeresita Guadalupe López-Aceves
Teresita Guadalupe López-Aceves
ECElvia Coballase
Elvia Coballase
FEFrancisco Estrada-Rojo
Francisco Estrada-Rojo
AVAmerica Vanoye-carlo
America Vanoye-carlo
LCLiliana Carmona-Aparicio
Liliana Carmona-Aparicio
CLClaudia León-Sicairos
Claudia León-Sicairos
Permethrin (PERM) is a member of the class I family of synthetic pyrethroids. Human use has shown that it affects different systems, with wide health dysfunctions. Our aim was to determine bioenergetics, neuroinflammation and morphology changes, as redox markers after subacute exposure to PERM in rats. We used MDA determination, protein carbonyl assay, mitochondrial O2 consumption, expression of pro-inflammatory cytokines and a deep histopathological analysis of the hippocampus. PERM (150 mg/kg and 300 mg/kg body weight/day, o.v.) increased lipoperoxidation and carbonylated proteins in a dose-dependent manner in the brain regions. The activities of antioxidant enzymes glutathione peroxidase, reductase, S-transferase, catalase, and superoxide dismutase showed an increase in all the different brain areas, with dose-dependent effects in the cerebellum. Cytokine profiles (IL-1β, IL-6 and TNF-α) increased in a dose-dependent manner in different brain tissues. Exposure to 150 mg/kg of permethrin induced degenerated and/or dead neurons in the rat hippocampus and induced mitochondrial uncoupling and reduction of oxidative phosphorylation and significantly decreased the respiratory parameters state 3-associated respiration in complex I and II. PERM exposure at low doses induces reactive oxygen species production and imbalance in the enzymatic antioxidant system, increases gene expression of pro-inflammatory interleukins, and could lead to cell damage mediated by mitochondrial functional impairment.

29 November 2017 in BioMed Research International
Verified
Journal Article
Open access
PDF file
LVLeticia Verdugo-Diaz
Leticia Verdugo-Diaz
FEFrancisco Estrada-Rojo
Francisco Estrada-Rojo
AGAron Garcia-Espinoza
Aron Garcia-Espinoza
EHEduardo Hernandez-Lopez
Eduardo Hernandez-Lopez
AHAlejandro Hernandez-Chavez
Alejandro Hernandez-Chavez
LNLuz Navarro
Luz Navarro
Traumatic brain injury (TBI) represents a significant public health concern and has been associated with high rates of morbidity and mortality. Although several research groups have proposed the use of repetitive transcranial magnetic stimulation (rTMS) to enhance neuroprotection and recovery in patients with TBI, few studies have obtained sufficient evidence regarding its effects in this population. Therefore, we aimed to analyze the effect of intermediate-frequency rTMS (2 Hz) on behavioral and histological recovery following TBI in rats. Male Wistar rats were divided into six groups: three groups without TBI (no manipulation, movement restriction plus sham rTMS, and movement restriction plus rTMS) and three groups subjected to TBI (TBI only, TBI plus movement restriction and sham rTMS, and TBI plus movement restriction and rTMS). The movement restriction groups were included so that rTMS could be applied without anesthesia. Our results indicate that the restriction of movement and sham rTMS per se promotes recovery, as measured using a neurobehavioral scale, although rTMS was associated with faster and superior recovery. We also observed that TBI caused alterations in the CA1 and CA3 subregions of the hippocampus, which are partly restored by movement restriction and rTMS. Our findings indicated that movement restriction prevents damage caused by TBI and that intermediate-frequency rTMS promotes behavioral and histologic recovery after TBI.